REVIEW
Published on 05 Aug 2026
Envafolimab – novel anti-PD-1/PD-L1 antibody in cancer treatment
doi 10.3389/fimmu.2026.1918429
- 454 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Overcoming bottlenecks in cancer immunotherapy: Mechanisms of immune escape and translational strategies
Overcoming bottlenecks in cancer immunotherapy: Mechanisms of immune escape and translational strategies
434
Total downloads
4,056
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 21 Jul 2026
Targeting stroma-mediated T-cell exclusion and functional exhaustion in pancreatic ductal adenocarcinoma through CXCR4 and PD-1 blockade
doi 10.3389/fimmu.2026.1844781
- 839 views
OPINION
Published on 17 Apr 2026
HLA incompatibility mitigation strategies in off-the-shelf cancer immunotherapies: clinical implications and a practical framework for strategy selection and combination
doi 10.3389/fimmu.2026.1803331
- 1,016 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.4 impact factor
- 6.6 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: